| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/28/2013 | US20130053446 Pharmaceutical preparations having individualized dosage and structure |
| 02/28/2013 | US20130053444 Dp2 antagonist and uses thereof |
| 02/28/2013 | US20130053436 Compounds, compositions and methods |
| 02/28/2013 | US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053408 Methods and compositions utilizing quinazolinones |
| 02/28/2013 | US20130053402 Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053400 Oligomer-antihistamine conjugates |
| 02/28/2013 | US20130053399 Methods of administering antihistamines |
| 02/28/2013 | US20130053397 Indoles |
| 02/28/2013 | US20130053395 Pyrazolopyridine kinase inhibitors |
| 02/28/2013 | US20130053394 Pyrazolopyrimidine kinase inhibitors |
| 02/28/2013 | US20130053388 Pyrazolopyrazine kinase inhibitors |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053371 Inhibitors of pi3 kinase |
| 02/28/2013 | US20130053362 Heterocyclic compounds and uses thereof |
| 02/28/2013 | US20130053356 2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3 |
| 02/28/2013 | US20130053353 Compositions, gels and foams with rheology modulators and uses |
| 02/28/2013 | US20130053346 Pyrimido-pyridazinone compounds and methods of use thereof |
| 02/28/2013 | US20130053340 Intestinal barrier integrity |
| 02/28/2013 | US20130053334 Monomers and oligonucleotides comprising cycloaddition adduct(s) |
| 02/28/2013 | US20130053313 New formulation for increasing bioavailability of neurturin |
| 02/28/2013 | US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 02/28/2013 | US20130053303 Compounds for enzyme inhibition |
| 02/28/2013 | US20130053301 Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| 02/28/2013 | US20130052279 Reverse micelle system comprising metal ions and use thereof |
| 02/28/2013 | US20130052235 Herpes simplex virus nanoemulsion vaccine |
| 02/28/2013 | US20130052231 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |
| 02/28/2013 | US20130052230 Salmonella vaccine |
| 02/28/2013 | US20130052228 Attenuated fish vaccine following culture in iron limited media |
| 02/28/2013 | US20130052226 Compositions and methods for preventing or treating a human parvovirus infection |
| 02/28/2013 | US20130052225 Infectious dna vaccines against chikungunya virus |
| 02/28/2013 | US20130052224 Production of poliovirus at high titers for vaccine production |
| 02/28/2013 | US20130052223 Universal vaccine against h5n1 lineages |
| 02/28/2013 | US20130052221 Dna-protein vaccination protocols |
| 02/28/2013 | US20130052220 Yeast-hiv antigen compositions and methods of using the same |
| 02/28/2013 | US20130052219 Preparation method of virus expressing alpha-galactose epitope and vaccine |
| 02/28/2013 | US20130052217 Tumor vaccination involving a humoral immune response against self-proteins |
| 02/28/2013 | US20130052216 Targeted heterologous antigen presentation on calicivirus virus-like particles |
| 02/28/2013 | US20130052214 Identification of a peptide(s) that induces autoimmune anterior uveitis |
| 02/28/2013 | US20130052212 Method for allogeneic cell therapy |
| 02/28/2013 | US20130052211 Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof |
| 02/28/2013 | US20130052210 Use of ccl1 in therapy |
| 02/28/2013 | US20130052208 Process for Preparing an Immunoglobulin Composition |
| 02/28/2013 | US20130052200 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 02/28/2013 | US20130052196 Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments |
| 02/28/2013 | US20130052195 Compositions Comprising TNF-alpha and IL-6 Antagonists and Methods of Use Thereof |
| 02/28/2013 | US20130052193 CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR TOLL-LIKE RECEPTOR 2 (TLR2) |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052190 CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions |
| 02/28/2013 | US20130052174 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof |
| 02/28/2013 | US20130052171 Immunomodulatory isolated lactobacillus strainand application thereof |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052163 Human Rhinovirus (HRV) Antibodies |
| 02/28/2013 | US20130052162 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 02/28/2013 | US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof |
| 02/28/2013 | US20130052131 Nanoparticles, methods of making nanoparticles, and methods of use |
| 02/28/2013 | CA2846416A1 Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement |
| 02/28/2013 | CA2845872A1 Herpes simplex virus nanoemulsion vaccine |
| 02/27/2013 | EP2562156A2 Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2561869A1 Skin collagen production promoter |
| 02/27/2013 | EP2561767A1 Epicatechin for alleviating symptoms of allergy |
| 02/27/2013 | EP2560990A1 Novel allergen |
| 02/27/2013 | EP2560981A2 Synthetic oligosaccharides for staphylococcus vaccine |
| 02/27/2013 | EP2560969A1 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists |
| 02/27/2013 | EP2560691A2 Process for preparing an immunoglobulin composition |
| 02/27/2013 | EP2560688A1 Combination of drugs with protein-binding prodrugs |
| 02/27/2013 | EP2560679A1 Eczema treatment |
| 02/27/2013 | EP2560671A2 High affinity leptins and leptin antagonists |
| 02/27/2013 | EP2560635A2 Anti-viral compounds |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN102947336A Methods of treating diabetes with dll4 antagonists |
| 02/27/2013 | CN102947333A 抗体组合物 Antibody composition |
| 02/27/2013 | CN102942616A Peptide capable of binding to immunoglobulin |
| 02/27/2013 | CN102942520A p38 MAP激酶抑制剂 p38 MAP kinase inhibitors |
| 02/27/2013 | CN102940883A Therapeutic composition to improve the effect of the therapy with anti-epidermal growth factor receptor antibodies |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940877A Application of polypeptide DM29 in preparing drugs for increasing natural immunity of goats |
| 02/27/2013 | CN102940784A Active fresh Gastrodia elata full pulp soft capsule |
| 02/27/2013 | CN102940783A Active fresh Gastrodia elata superfine powder and preparation method thereof |
| 02/27/2013 | CN102940781A Anti-aging and dredging Chinese medicinal composition |
| 02/27/2013 | CN102940697A Medicine for treating allergic rhinitis and bronchial asthma |
| 02/27/2013 | CN102940652A Eubacterium biforme preparation and use thereof |
| 02/27/2013 | CN102940648A Bee propolis soft capsule and manufacturing process thereof |
| 02/27/2013 | CN102940632A Application of FK506-A compound in preparation of immunosuppressant |
| 02/27/2013 | CN102940630A Medicinal composition containing temsirolimus and preparation method of medicinal composition |
| 02/27/2013 | CN102940617A Desloratadine oral dispersible film |
| 02/27/2013 | CN102940608A Tripterine controlled-release solid dispersion |
| 02/27/2013 | CN102940149A Poultry traditional Chinese medicine feed additive |
| 02/27/2013 | CN102634431B Method for brewing dendrobium nobile wine |
| 02/27/2013 | CN102335417B Health-care product for restoring physical strength in later period of cold |
| 02/27/2013 | CN102228680B Thymosin phospholipids/bile salt compound micelle and preparation method and preparation thereof |
| 02/27/2013 | CN101948549B Sulphating modification method of gynostemma pentaphylla polysaccharide |
| 02/27/2013 | CN101869576B New application of fig polysaccharide |
| 02/27/2013 | CN101766657B Compound for activating immune cell and preparation method thereof |
| 02/27/2013 | CN101522683B Pyraz0l0(l,5-A) (1, 3, 5) triazine and pyrazolo (1, 5-A) pyrimidine derivatives useful as protein kinase inhibitors |
| 02/26/2013 | US8383587 Prevention of allergy at weaning |
| 02/26/2013 | US8383153 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 02/26/2013 | US8383120 Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate |
| 02/26/2013 | CA2674885C Anti-ige vaccines |